SEARCH

SEARCH BY CITATION

References

  • 1
    International Agency for Research on Cancer. In: VainioH, BianchiniF, eds. IARC Handbooks of Cancer Prevention, Vol. 7: Breast cancer screening. Lyon: IARC Press, 2002.
  • 2
    Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993; 85: 164456.
  • 3
    Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359: 90919.
  • 4
    Warren R, Allgood P, Hunnam G, Godward S, Duffy S. An audit of assessment procedures in women who develop breast cancer after a negative result. J Med Screen 2004; 11: 1806.
  • 5
    Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 1999; 91: 20208.
  • 6
    PerryN, BroedersM, de WolfC, TörnbergS, eds. European guidelines for quality assurance in mammography screening. Luxembourg: Office for Official Publications of the European Communities, 2001.
  • 7
    Day N, McCann J, Camilleri-Ferrante C, Britton P, Hurst G, Cush S, Duffy S. Monitoring interval cancers in breast screening programmes: the East Anglian experience. J Med Screen 1995; 2: 1805.
  • 8
    Everington D, Gilbert FJ, Tyack C, Warner J. The Scottish breast screening programme's experience of monitoring interval cancers. J Med Screen 1999; 6: 217.
  • 9
    Faux AM, Richardson DC, Lawrence GM, Wheaton ME, Wallis MG. Interval breast cancers in the NHS Breast Screening Programme: does the current definition exclude too many? J Med Screen 1997; 4: 16973.
  • 10
    Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, van Ineveld BM, Broeders MJ, de Bruyn AE, van der Maas PJ. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999; 81: 9127.
  • 11
    Ganry OF, Peng J, Raverdy NL, Dubreuil AR. Interval cancers in a French breast cancer-screening programme (Somme Department). Eur J Cancer Prev 2001; 10: 26974.
  • 12
    Kavanagh AM, Mitchell H, Farrugia H, Giles GG. Monitoring interval cancers in an Australian mammographic screening programme. J Med Screen 1999; 6: 13943.
  • 13
    Moss SM, Coleman DA, Ellman R, Chamberlain J, Forrest AP, Kirkpatrick AE, Thomas BA, Price JL. Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer. Eur J Cancer 1993; 29A: 2558.
  • 14
    Wang H, Bjurstam N, Bjorndal H, Braaten A, Eriksen L, Skaane P, Vitak B, Hofvind S, Thoresen SO. Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT. Int J Cancer 2001; 94: 5948.
  • 15
    Törnberg S, Codd M, Rodrigues V, Segnan N, Ponti A. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres. J Med Screen 2005; 12: 439.
  • 16
    Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 2002; 9: 1538.
  • 17
    Taylor R, Supramaniam R, Rickard M, Estoesta J, Moreira C. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes. J Med Screen 2002; 9: 205.
  • 18
    Yankaskas BC, Klabunde CN, Ancelle-Park R, Renner G, Wang H, Fracheboud J, Pou G, Bulliard J-L. International comparison of performance measures for screening mammography: can it be done? J Med Screen 2004; 11: 18793.
  • 19
    Klabunde C, Bouchard F, Taplin S, Scharpantgen A, Ballard-Barbash R. Quality assurance for screening mammography: an international comparison. J Epidemiol Community Health 2001; 55: 20412.
  • 20
    Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard-Barbash R; on behalf of International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 1998; 27: 73542.
  • 21
    Bulliard J-L, De Landtsheer J-P, Levi F. Results from the Swiss mammography screening pilot programme. Eur J Cancer 2003; 38: 17608.
  • 22
    Duijm LEM, Groenewoud JH, Jansen FH, Fracheboud J, van Beek M, de Koning HJ. Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening. Br J Cancer 2004; 91: 17959.
  • 23
    Amos AF, Kavanagh AM, Cawson J. Radiological review of interval cancers in an Australian mammographic screening programme. J Med Screen 2000; 7: 1849.
  • 24
    Liston J. Are too many breast cancers missed at assessment? Breast 2000; 9: 2017.
  • 25
    McCann J, Britton PD, Warren RM, Hunnam G. Radiological peer review of interval cancers in the East Anglian breast screening programme: what are we missing? J Med Screen 2001; 8: 7785.
  • 26
    Saarenmaa I, Salminen T, Geiger U, Holli K, Isola J, Kärkkäinen A, Pakkanen J, Piironen A, Salo A, Hakama M. The visibility of cancer on earlier mammograms in a population-based screening programme. Eur J Cancer 1999; 35: 111822.
  • 27
    National Health Service. Breast Screening Programme, England: 2003–04. Sheffield: NHS, 2005.
  • 28
    Kerlikowske K, Smith-Bindman R, Abraham LA, Lehman CD, Yankaskas BC, Ballard-Barbash R, Barlow WE, Voeks JH, Geller BM, Carney PA, Sickles EA. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology 2005; 234: 68492.
  • 29
    Exbrayat C, Garnier A, Colonna M, Assouline D, Salicru B, Winckel P, Menegoz F, Bolla M. Analysis and classification of interval cancers in a French breast cancer screening programme (département of Isère). Eur J Cancer Prev 1999; 8: 25560.
  • 30
    Prior P, Woodman CB, Wilson S, Threlfall AG. Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer. J Med Screen 1996; 3: 11922.
  • 31
    Schouten LJ, de Rijke JM, Schlangen JT, Verbeek AL. Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, The Netherlands. J Med Screen 1998; 5: 3741.
  • 32
    Kavanagh AM, Amos AF, Marr GM. The ascertainment and reporting of interval cancers within the BreastScreen Australia Program. NHMRC National Breast Cancer Centre, 1999 (available at http://www.nbcc.org.au/bestpractice/resources/ICP_reportinginternalcancers.pdf).